CAS: 896731-82-1 - Conatumumab
Formula:Unspecified
- Synonyms:
- Conatumumab
- Immunoglobulin G1, anti-(human cytokine receptor DR5 (death receptor 5)) (human monoclonal XG1-048 v w heavy chain), disulfide with human monoclonal XG1-048 v w light chain, dimer
- Immunoglobulin G1, anti-(human TRAIL receptor 2) (human monoclonal XG1-048 v w heavy chain), disulfide with human monoclonal XG1-048 v w light chain, dimer
- AMG 655
- TRAIL-R2 mAb
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Conatumumab REF: TM-T76787CAS: 896731-82-1 | 95% - SDS-PAGE:95% SEC-HPLC:95% | 353.00 €~1,427.00 € | Tue 15 Oct 24 |
 | Conatumumab REF: 3D-CLA1171CAS: 896731-82-1 | - - - | To inquire | Thu 24 Oct 24 |
Conatumumab
CAS:896731-82-1
Conatumumab (AMG 655) targets DR5 to induce apoptosis in tumors, with Kd of 1 nM …
Purity:
95% - SDS-PAGE:95% SEC-HPLC:95%
Color and Shape:
Solid
Molecular weight:
145.65 (kDa)
Ref: TM-T76787
| 1mg | 353.00 € | ||
| 5mg | 891.00 € | ||
| 10mg | 1,427.00 € |
Estimated delivery in United States, on Tuesday 15 Oct 2024
Conatumumab
CAS:896731-82-1
A fully human monoclonal agonist antibody against the extracellular domain of human TRAIL.
Ref: 3D-CLA1171
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 24 Oct 2024
